A Multi-center, Randomized, Open-label, Parallel-group, Phase 2 Study to Evaluate the Efficacy and Safety of VS-101 in Combination With Chemoradiotherapy (CRT) in Patients With Head and Neck Cancer
Latest Information Update: 14 May 2025
At a glance
- Drugs Aripiprazole (Primary) ; Cisplatin
- Indications Carcinoma; Head and neck cancer; Hypopharyngeal cancer; Laryngeal cancer; Mouth neoplasm; Oropharyngeal cancer; Squamous cell cancer
- Focus Therapeutic Use
- Sponsors VS PharmTech
Most Recent Events
- 06 May 2025 Status changed from planning to not yet recruiting.
- 20 Dec 2022 New trial record